ASPS Welcomes MTF Biologics as Gold Sponsor, Galderma and Evolus as Silver Sponsors of Plastic Surgery The Meeting
ARLINGTON HEIGHTS, IL – The American Society of Plastic Surgeons (ASPS) is pleased to welcome MTF Biologics as a Gold sponsor, as well as Galderma and Evolus as Silver sponsors for the Society’s 89th annual scientific conference, Plastic Surgery The Meeting.
The Meeting features the latest research, techniques and technology in cosmetic and reconstructive plastic surgery. The premier educational and networking event of the year for domestic and international plastic surgeons will be hosted live online Oct. 16-18 with original on-demand programming available over the course of 50 days, from Oct. 9-Nov. 30. The virtual meeting features nearly 100 live sessions, more than 50 on-demand sessions and over 1,300 abstract presentations.
MTF Biologics Plastic and Reconstructive Surgery provides innovative solutions in breast reconstruction, craniofacial procedures, burn injuries and aesthetic surgery. From orthopedics to plastic and reconstructive surgery, the world’s leading tissue bank has become a force in scientific progress and patient advocacy.
“MTF Biologics is excited to be part of the virtual Plastic Surgery The Meeting to showcase our full portfolio of solutions for reconstructive and aesthetic procedures,” said Joe Yaccarino, President & CEO of MTF Biologics. “As we navigate this road to recovery, we are happy to be able to connect with the plastic surgery community through this virtual format and continue our support of ASPS.”
Galderma is a global dermatology company that partners with health care professionals to provide innovative medical solutions to patients with skin health needs, and Heron Therapeutics, Inc., is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.
“Galderma is proud to partner with ASPS to drive the future of aesthetics forward. We are committed to ensuring industry-leading education is available with partners like ASPS and programs like GAIN, Galderma’s Aesthetic Injector Network, in an engaging virtual format,” said Alisa Lask, Vice President & General Manager, US Aesthetic Business.
Evolus is a medical aesthetics company that provides physicians and their patients with innovative treatment and procedure options.
“We want to thank ASPS and plastic surgeons for their support of Evolus as we enter our second year on the market. We are firmly committed to the plastic surgery community and are pleased to continue our support of ASPS and the upcoming annual meeting,” said David Moatazedi, President and CEO, Evolus.
The ASPS Premier Support program provides industry partners with increased visibility, additional benefits and greater recognition for their support at Plastic Surgery The Meeting. Partnering with ASPS provides unprecedented opportunities to communicate and engage with aesthetic and reconstructive plastic surgeons from around the world.
For more information, visit the Plastic Surgery The Meeting website.
Published at Tue, 22 Sep 2020 22:00:00 +0000